Phase II study of sorafenib combined with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma: Preliminary results

被引：0
|
作者：
Hongyun, L. [1 ]
Zhihong, C. [1 ]
Xiangqing, Y. [1 ]
Lu, S. [1 ]
Chuanliang, C. [1 ]
Xinan, S. [1 ]
Lin, S. [1 ]
Jun, G. [1 ]
机构：
[1] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16093
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors
    Jordan D. Berlin
    Dona B. Alberti
    Rhoda Z. Arzoomanian
    Chris A. Feierabend
    Kris J. Simon
    Kim A. Binger
    Rebecca M. Marnocha
    George Wilding
    Investigational New Drugs, 1998, 16 : 325 - 330
  • [32] A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and or metastatic solid tumors
    Berlin, JD
    Alberti, DB
    Arzoomanian, RZ
    Feierabend, CA
    Simon, KJ
    Binger, KA
    Marnocha, RM
    Wilding, G
    INVESTIGATIONAL NEW DRUGS, 1999, 16 (04) : 325 - 330
  • [33] CHEMOTHERAPY WITH GEMCITABINE AND 5-FLUOROURACIL IN PATIENTS WITH POOR PROGNOSIS METASTATIC RENAL CELL CANCER - SIGNIFICANT PALLIATIVE ROLE?
    Janjic, A.
    Bojanic, N.
    Micic, S.
    Vuksanovic, A.
    Tulic, C.
    Pejcic, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 589 - 589
  • [34] Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2)
    André, T
    Noirclerc, M
    Hammel, P
    Meckenstock, R
    Landi, B
    Cattan, S
    Selle, F
    Codoul, JF
    Guerrier-Parmentier, B
    Mokhtar, R
    Louvet, C
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (8-9): : 645 - 650
  • [35] Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer
    Novarino, A
    Chiappino, I
    Bertelli, GF
    Heouaine, A
    Ritorto, G
    Addeo, A
    Bellone, G
    Merlano, M
    Bertetto, O
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 474 - 477
  • [36] Usefulness of Gemcitabine Combined With 5-Fluorouracil and Cisplatin (GFP) in Patients for Unresectable Biliary Carcinoma
    Morine, Yuji
    Shimada, Mitsuo
    Ikegami, Toru
    Imura, Satoru
    Kanemura, Hirohumi
    Arakawa, Yusuke
    Hanaoka, Jun
    Kanamoto, Mami
    Nii, Akira
    HEPATO-GASTROENTEROLOGY, 2009, 56 (90) : 307 - 312
  • [37] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients
    Alliot, C
    ANNALS OF ONCOLOGY, 2004, 15 (10) : 1576 - 1577
  • [38] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Poplin, E
    Roberts, J
    Tombs, M
    Grant, S
    Rubin, E
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 57 - 62
  • [39] Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC)
    Buti, Sebastiano
    Brighenti, Matteo
    Bongiovanni, Cristiano
    Buzio, Carlo
    Chiesa, Matteo Dalla
    Alberici, Federico
    Passalacqua, Rodolfo
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (07) : 780 - 786
  • [40] 5-FLUOROURACIL DOSE INTENSITY INCREASE IN 5-FLUOROURACIL AND LEUCOVORIN COMBINATION - RESULTS OF A PHASE II STUDY
    CASCINU, S
    FEDELI, A
    FEDELI, SL
    CATALANO, G
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (01) : 51 - 54
12345